Meta-Analysis
Copyright ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 26, 2019; 7(18): 2760-2775
Published online Sep 26, 2019. doi: 10.12998/wjcc.v7.i18.2760
Respiratory training interventions improve health status of heart failure patients: A systematic review and network meta-analysis of randomized controlled trials
Mei-Hua Wang, Mei-Ling Yeh
Mei-Hua Wang, Mei-Ling Yeh, School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei 11219, Taiwan
Author contributions: All authors equally contributed to this paper.
Conflict-of-interest statement: The authors have no financial or any other kind of personal conflicts with this paper.
PRISMA 2009 Checklist statement: The manuscript has been checked according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Mei-Ling Yeh, PhD, DMS, Professor, School of Nursing, National Taipei University of Nursing and Health Sciences, 365 Minte Road, Taipei 11219, Taiwan. meiling@ntunhs.edu.tw
Telephone: +886-2-28227101
Received: January 30, 2019
Peer-review started: January 31, 2019
First decision: May 31, 2019
Revised: July 4, 2019
Accepted: July 27, 2019
Article in press: July 27, 2019
Published online: September 26, 2019
ARTICLE HIGHLIGHTS
Research background

For heart failure, the estimated all-cause mortality rate is 8% and 25% for 30-d and 1-year periods, respectively. It is currently expected that 8 million adults will be diagnosed with heart failure by 2030. The annualized lifetime costs associated with heart failure have been estimated at $868~25532 per patient. Therefore, the care needs of heart failure patients and the high societal costs associated with caring for this growing patient population are issues that will become increasingly important and that, eventually, must be addressed effectively.

Research motivation

Clinical guidelines recommend condition-appropriate exercises as a complementary therapy for heart failure patients in addition to regular pharmacological treatment. Machine-assisted respiratory training such as inspiratory muscle training (IMT) and non-machine-assisted respiratory training such as breathing exercises may improve dyspnea-related physical performance and quality of life (QoL) in heart failure patients. Heart rate and left ventricular ejection fraction (LVEF) are important indicators of cardiac function which is affected by exercise capacity and assessed using the 6-minute walking distance test (6MWT) and peak oxygen uptake (VO2 peak). Currently, most research analysis to date has focused on pairwise comparisons of exercise effects, such as IMT vs aerobic exercises and IMT vs breathing exercises, and the respective effects of IMT regimens at different levels of intensity. Thus, clinical data on supplemental therapies for heart failure patients is inadequate.

Research objectives

To determine the effect of respiratory training interventions on physical performance and quality of life in patients with heart failure.

Research methods

This was a systematic review and network meta-analysis study. A literature search of 11 electronic databases was conducted for randomized controlled trials on heart failure. Respiratory training interventions were grouped as seven categories and four outcomes. The random-effects model, side-splitting model, and the surface under the cumulative ranking curve were used to test and analyze data.

Research results

The interventions from the included studies were grouped as IMT_Pn (inspiratory muscle training without pressure or < 10% MIP), IMT_Pl (inspiratory muscle training with low pressure, 10%-15% MIP), IMT_Pm (inspiratory muscle training with medium pressure, 30%-40% MIP), IMT_Ph (inspiratory muscle training with high pressure, 60% MIP or MIP plus aerobics), Qi_Ex (tai chi, yoga, or breathing exercise), Aerobics (aerobic exercise or weight training), and none (usual care, standard treatment, or education). A significant difference among these groups was found in overall intervention effect on heart rate [95%CI: -1.30-(-0.39)], VO2 peak (95%CI: 0.77-2.17), 6MWT (95%CI: 0.69-1.43), and QoL [95%CI: -1.54 –(-0.73)]. Further, a significant difference was found in heart rate between Qi_Ex and IMT_Pn (95%CI: 0.58-3.13), and in QoL between IMT_Pm and IMT_Pn [95%CI: -3.72-(-0.28)]. The 6MWT of IMT_Ph differed significantly from that of IMT_Pm [95%CI: -3.51-(-0.69)], IMT_Pl [95%CI: -3.89-(-1.49)], and IMT_Pn [95%CI: -7.56-(-2.75)].

Research conclusions

This systematic review and network meta-analysis study supports that respiratory training interventions, including IMT, tai chi, yoga, and breathing exercises, are effective strategies for improving cardiac function, exercise capacity, and QoL for adult heart failure patients. Machine-assisted respiratory training in hospital settings should be prioritized over respiratory training provided in non-hospital settings. Specifically, IMT with high pressure effectively improves cardiac function, whereas IMT with moderate pressure effectively improves QoL. In home settings, non-machine-assisted respiratory training such as tai chi, yoga, and breathing exercise effectively improves heart rate.

Research perspectives

This study offers clinical staff both practical insights and practical, setting-based therapeutic strategies for improving the condition of their heart failure patients. Respiratory training interventions generally improve cardiac function, exercise capacity, and QoL in adult heart failure patients. However, the result of the network meta-analysis did not meet requirements for the test for discordancy in the treatment effect of LVEF. The reason for this may be the differences in the severity of heart failure among the various research samples. In addition, seven of the included studies had attrition rates in excess of 20%, with IMT studies accounting for four of these. Approximately 65.3% of the participant loss in these IMT studies were due to their heart failure prognosis.